CUAMC
PYXS icon

China Universal Asset Management Company’s Pyxis Oncology PYXS Stock Holding History

China Universal Asset Management Company’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.4K Sell
10,083
-966
-9% -$1.85K ﹤0.01% 485
2026
Q1 		$16.1K Buy
11,049
+903
+9% +$1.36K ﹤0.01% 495
2025
Q4 		$11.7K Sell
10,146
-725
-7% -$2.56K ﹤0.01% 491
2025
Q3 		$24.1K Sell
10,871
-1,571
-13% -$2.26K ﹤0.01% 457
2025
Q2 		$13.7K Buy
12,442
+514
+4% +$579 ﹤0.01% 459
2025
Q1 		$11.7K Sell
11,928
-681
-5% -$909 ﹤0.01% 473
2024
Q4 		$19.7K Buy
+12,609
New +$36.4K ﹤0.01% 485

Other funds holding PYXS

HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
HIMS
Hager Investment Management Services New London, New Hampshire $217M AUM 56.89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FUBT
First United Bank & Trust Oakland, Maryland $348M AUM 25.01% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

China Universal Asset Management Company's PYXS Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Pyxis Oncology (PYXS) stake by 8.7% in Q2 2026, selling an estimated $1.85K and leaving 10,083 shares worth $30.4K. The position accounts for ﹤0.01% of the portfolio, ranked #485.

China Universal Asset Management Company first reported a position in PYXS in Q4 2024 and has held it in 7 quarters since. 7 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • China Universal Asset Management Company held 10,083 shares of Pyxis Oncology worth $30.4K as of Q2 2026.
  • China Universal Asset Management Company sold 966 Pyxis Oncology shares in Q2 2026, an estimated $1.85K.
  • Pyxis Oncology made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #485 holding.
  • China Universal Asset Management Company first reported a position in Pyxis Oncology in Q4 2024 and has held it in 7 quarters since.
  • 7 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.